The recent CHS-Labcorp deal is one of many that highlights a market shift. Clinical lab outreach services, once viewed as strategic assets, are being sold off rapidly as hospitals recenter around core services and offload logistical burdens. This year, 30% of lab mergers and acquisitions involve outreach agreements, with national lab companies seeing opportunities to […]
What’s Behind the Surge in Laboratory Outreach Sales?
Also in the August 25, 2025 issue, The Dark Report shows how labs can profit from pharma companies
- By Robert Michel
- > From the Volume XXXII, No. 12 - August 25, 2025 Issue
